During the past decade, Allergopharma GmbH & Co. KG conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergopharma GmbH & Co. KG" are "Allergy" (3 trials), "Rhinoconjunctivitis" (3 trials), "Birch Pollen Allergy" (2 trials), "Grass Pollen Allergy" (2 trials) and "Allergic Asthma" (1 trials). Many other conditions were trialed in "Allergopharma GmbH & Co. KG" in a lesser frequency.

Most popular intervention types in "Allergopharma GmbH & Co. KG" are "Biological" (13 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Recombinant birch pollen" (2 trials), "AL0704rP" (1 trials), "Acaroid" (1 trials) and "Allergovit 6-grasses" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergopharma GmbH & Co. KG" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Allergopharma GmbH & Co. KG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Allergopharma GmbH & Co. KG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergopharma GmbH & Co. KG, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".